Exelon Transdermal Patch

rivastigmine · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Exelon Transdermal Patch, covering 2017-02-28 to 2017-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients [NA]